(lp0
S"Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All ... Motley Fool - 22 hours ago Among them were Esperion Therapeutics  and The Medicines Company , which dropped by 21% and 14%, respectively, by mid-day.Medicines Co. hits mark in ORION, plans PCSK9 Phase 3 - BioPharma DiveAmgen's aftershocks rattle the PCSK9 parade - STAT"
p1
aS'The Medicines Company and Alnylam Pharmaceuticals Report Positive Final ... Business Wire  - 23 hours ago PARSIPPANY, N.J. &amp; CAMBRIDGE, Mass.----The Medicines Company  and Alnylam Pharmaceuticals, Inc.  today announced positive final results from the ORION-1 Phase II study of inclisiran,&nbsp;...'
p2
aS'The Medicines Company  Moves Lower on Volume Spike for March 17 Equities.com - 18 hours ago The Medicines Company  traded on unusually high volume on Mar. 17, as the stock lost 7.99% to close at $48.38. On the day, The Medicines Company saw 20.39 million shares trade hands on 108,093 trades. Considering that the stock averages&nbsp;...Taking a Look at the Data Behind The Medicines Company  - StockNewsJournal'
p3
aS"The Medicines Company to Host Conference Call and Webcast at Upcoming American ... Yahoo Finance - Mar 6, 2017 The Medicines Company  will host a conference call and webcast on Friday, March 17, 2017, at 3:30 p.m., Eastern Time, to review data from the ORION-1 Phase II study of inclisiran, the Company's PCSK9 synthesis inhibitor."
p4
aS"The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of ... Business Wire  - Mar 14, 2017 PARSIPPANY, N.J.----The Medicines Company  today announced that it will webcast, over the internet simultaneously with the presentation, the detailed results from its ORION-1 Phase II study of inclisiran, the Company's&nbsp;..."
p5
aS'The Medicines Company Partnering Deals and Alliances 2010 to 2017 PR Newswire  - Feb 27, 2017 Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&amp;A deals since 2010 to present date based on headline value.'
p6
aS'Earnings Reaction History: The Medicines Company, 44.4% Follow-Through ... Nasdaq - Feb 28, 2017 The Medicines Company  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.'
p7
aS'The Medicines Company  Breaks into New 52-Week High on March 15 Session Equities.com - Mar 15, 2017 Shares of The Medicines Company  broke into a new 52-week high yesterday, hitting a peak of $54.89. Shares closed at $54.41 after opening at $52.64 for a move of 4.01%.'
p8
aS'The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results Yahoo Finance - Feb 28, 2017 Driven by strong execution against our strategic priorities, 2016 was a transformative year for the Company, said Clive Meanwell, M.D.'
p9
aS'The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial ... Yahoo Finance - Feb 17, 2017 The Medicines Company is a biopharmaceutical company driven by an overriding purpose - to save lives, alleviate suffering and contribute to the economics of healthcare.'
p10
a.